Bristol-Myers Squibb Co. (BMY) reported fourth-quarter net earnings attributable to the company of $8.03 billion or $4.06 per share, compared to $1.24 billion or $0.63 per share for the same period in 2008. The fourth quarter 2009 net earnings included a $7.2 billion after tax gain, or $3.62 per share, attributed to the split-off of Mead Johnson Nutrition Company, which is recorded as discontinued operations.
Non-GAAP net earnings from continuing operations attributable to Bristol-Myers Squibb Company were $928 million or $0.47 per share, compared to $804 million or $0.40 per share for the same period in 2008.
Net sales for the quarter were $5.03 billion, compared to $4.54 billion in the prior year quarter.
Bristol-Myers expects its 2010 GAAP EPS from continuing operations to be in the range of $1.94 to $2.04 and its non-GAAP EPS from continuing operations to be between $2.15 and $2.25. The 2010 guidance assumptions include mid single-digit revenue growth. Analysts polled by Thomson Reuters expect the company to report earnings of $2.19 per share on revenues of $19.83 billion for fiscal 2010. Analysts' estimates typically exclude special items.
The company has previously provided guidance that it expected non-GAAP EPS to grow at a minimum of 15% compound annual growth rate from the 2007 base through 2010 without rebasing for the sale of the ConvaTec business. If the company meets its expected 2010 non-GAAP EPS from continuing operations guidance, it will exceed the prior 15% minimum three-year compound annual growth rate guidance.
For comments and feedback contact: editorial@rttnews.com
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.